Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kidney Biomarkers in HIV Patients (HIVOL 2)
NCT02667678Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Feb 2016
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoint: Stage of chronic kidney disease at Day 1. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02667678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667678.